These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37055181)

  • 1. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.
    Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
    J Pharmacol Exp Ther; 2021 Oct; 379(1):74-84. PubMed ID: 34330748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington's disease model mice.
    Pancani T; Day M; Tkatch T; Wokosin DL; González-Rodríguez P; Kondapalli J; Xie Z; Chen Y; Beaumont V; Surmeier DJ
    Nat Commun; 2023 Mar; 14(1):1398. PubMed ID: 36914640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
    Wu C; Yin H; Fu S; Yoo H; Zhang M; Park H
    Biochem Biophys Res Commun; 2024 Jan; 691():149246. PubMed ID: 38029540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.
    Yu D; Zarate N; White A; Coates D; Tsai W; Nanclares C; Cuccu F; Yue JS; Brown TG; Mansky RH; Jiang K; Kim H; Nichols-Meade T; Larson SN; Gundry K; Zhang Y; Tomas-Zapico C; Lucas JJ; Benneyworth M; Öz G; Cvetanovic M; Araque A; Gomez-Pastor R
    Acta Neuropathol Commun; 2022 Jun; 10(1):83. PubMed ID: 35659303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
    Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
    PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical correlates of synapse density in a Huntington's disease mouse model.
    Zarate N; Gundry K; Yu D; Casby J; Eberly LE; Öz G; Gomez-Pastor R
    J Neurochem; 2023 Jan; 164(2):226-241. PubMed ID: 36272099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
    Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
    J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington's Mice.
    Li SH; Colson TL; Abd-Elrahman KS; Ferguson SSG
    Front Mol Neurosci; 2022; 15():801757. PubMed ID: 35185467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar stress controls mutant Huntington toxicity and monitors Huntington's disease progression.
    Sönmez A; Mustafa R; Ryll ST; Tuorto F; Wacheul L; Ponti D; Litke C; Hering T; Kojer K; Koch J; Pitzer C; Kirsch J; Neueder A; Kreiner G; Lafontaine DLJ; Orth M; Liss B; Parlato R
    Cell Death Dis; 2021 Dec; 12(12):1139. PubMed ID: 34880223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
    Heikkinen T; Lehtimäki K; Vartiainen N; Puoliväli J; Hendricks SJ; Glaser JR; Bradaia A; Wadel K; Touller C; Kontkanen O; Yrjänheikki JM; Buisson B; Howland D; Beaumont V; Munoz-Sanjuan I; Park LC
    PLoS One; 2012; 7(12):e50717. PubMed ID: 23284644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatum.
    Holley SM; Reidling JC; Cepeda C; Wu J; Lim RG; Lau A; Moore C; Miramontes R; Fury B; Orellana I; Neel M; Coleal-Bergum D; Monuki ES; Bauer G; Meshul CK; Levine MS; Thompson LM
    Mol Ther; 2023 Dec; 31(12):3545-3563. PubMed ID: 37807512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered mitochondrial Ca
    Yoo H; Park H
    Biochem Biophys Res Commun; 2024 Jul; 716():150010. PubMed ID: 38704892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.
    Creus-Muncunill J; Haure-Mirande JV; Mattei D; Bons J; Ramirez AV; Hamilton BW; Corwin C; Chowdhury S; Schilling B; Ellerby LM; Ehrlich ME
    J Neuroinflammation; 2024 Mar; 21(1):66. PubMed ID: 38459557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
    Wang N; Gray M; Lu XH; Cantle JP; Holley SM; Greiner E; Gu X; Shirasaki D; Cepeda C; Li Y; Dong H; Levine MS; Yang XW
    Nat Med; 2014 May; 20(5):536-41. PubMed ID: 24784230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
    Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
    J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-dependent impaired locomotion and motor coordination in the HdhQ200/200 mouse model of Huntington's Disease.
    Cao JK; Viray K; Zweifel L; Stella N
    Neurobiol Dis; 2019 Dec; 132():104607. PubMed ID: 31499139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.